Borregaard ASA: Borregaard invests further into Alginor 

Borregaard has participated with its fully diluted pro-rata share (35%) in the NOK 400 million capital raise in the marine biotech company Alginor to fund the next step of the biorefinery expansion. The funds from Borregaard were pre-committed. In aggregate the committed investments into Alginor from Borregaard will now total approximately NOK 408 million. 

Alginor intends to carry out a repair offering directed towards existing shareholders and potential new shareholders. A subsequent offering towards Borregaard will be made to ensure that Borregaard retains its 35% fully diluted ownership in Alginor.  

For more information about Alginor and the capital raise, see https://alginor.no/.  Contact: Director Investor Relations, Knut-Harald Bakke, +47 905 79 164

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

Borregaard ASA (TG:BO4)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024 Borregaard ASA 차트를 더 보려면 여기를 클릭.
Borregaard ASA (TG:BO4)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024 Borregaard ASA 차트를 더 보려면 여기를 클릭.